Rigel Pharmaceuticals
RIGL
#6656
Rank
C$1.08 B
Marketcap
C$57.49
Share price
-2.67%
Change (1 day)
-11.79%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): C$24.29

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$25.34. In 2025 the company made an earnings per share (EPS) of C$29.02 an increase over its 2024 EPS that were of C$1.42.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$24.29-16.31%
2025C$29.021944.44%
2024C$1.42
2022C-$4.88240%
2021C-$1.43-37.5%
2020C-$2.29-60%
2019C-$5.74-11.11%
2018C-$6.45-26.23%
2017C-$8.75-17.57%
2016C-$10.6125.42%
2015C-$8.46-42.72%
2014C-$14.77
2012C-$19.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$24.92-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.21-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
C-$0.54-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
C-$2.71-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA